↓ Skip to main content

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses

Overview of attention for article published in Health technology assessment : HTA / NHS R & D HTA Programme., November 2012
Altmetric Badge

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
111 Mendeley